The NanoMedicines Innovation Network (NMIN) is advancing “smart” medicines to cure disease by delivering small molecule drugs more specifically to disease sites and enabling the clinical use of gene therapies.

As part of its legacy strategy, the NMIN is creating an online database of Canadian nanomedicines researchers and the areas of expertise represented within their labs.  The database is intended as a tool to facilitate collaboration among nanomedicine researchers and labswithin and beyond the NMIN Network, now and in the future.

For more information and to complete the survey, please visit https://www.nanomedicines.ca/expertise-survey/